Treatment outcome of AT-B88 regimen for B-cell non-Hodgkin's lymphoma and surface immunoglobulin-positive acute lymphoblastic leukemia in children

International Journal of Hematology

Volumn 66, Issue 1, 1997, Pages 89-98

  Horibe, Keizo ^a   Akiyama, Yuichi ^b   Kobayashi, Masao ^c   Ishii, Eiichi ^d   Matsuyama, Takaharu ^e   Matsuzaki, Akinobu ^f   Minegishi, Masayoshi ^g   Ueda, Kazuhiro ^c  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY FACULTY OF MEDICINE   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^d Saga Prefectural Hospital Koseikan   (Japan)

^e JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

^f KYUSHU UNIVERSITY   (Japan)

^g TOHOKU UNIVERSITY   (Japan)

Author keywords

Acute lymphoblastic leukemia; B cell; Burkitt's lymphoma; Chemotherapy

Indexed keywords

DOXORUBICIN; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; FEVER; HUMAN; IMMUNE DEFICIENCY; INFECTION; INTRAVENOUS DRUG ADMINISTRATION; LIVER TOXICITY; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEPHROTOXICITY; NEUROTOXICITY; NEUTROPENIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 0031193570     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0925-5710(97)00579-3     Document Type: Article

References (19)

1. 2). N Engl J Med 1983;308:559-565.
2. Lemerle J. The treatment of B-cell non-Hodgkin's malignant lymphoma of childhood in Europe. Recent and ongoing studies. IARC Sci Publ 1985;60:383-398.
3. Muller-Wihrich St, Beck J, Henze G et al. BFM studie 1981/83 zur Behandlung hochmaligner Non-Hodgkin-Lymphome bei Kindern: Ergebnisse einer nach histologisch-immunologischem Typ und Ausbreitungsstadium stratifizierten Therapie. Klinj Padiat 1984;196:135-142.
4. Patte C, Philip T, Rodary C, et al. Improved survival rate in children with stage III and IV B cell non-Hodgkin's lymphomas and leukemia using multi-agent chemotherapy: results of a study of 114 children from the French Pediatric Oncology Society. J Clin Oncol 1986;4:1219-1226.
5. Murphy SB, Bowman WP, Abromowitch M et al. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (sIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol 1986;4:1732-1739.
6. Gadner H, Muller-Waeihrich St, Riehm H. Behandlungsstrategien der malignen Non-Hodgkin-Lymphome im Kindesalter. Onkologie 1986;9:126-130.
7. Murphy SB. Classification, staging and end results of treatment of childhood non-Hodgkin's lymphoma: dissimilarities from lymphomas in adults. Semin Oncol 1980;7:332-339.
8. Patte C, Philip T, Rodary C et al. High survival rate in advanced-stage B-cell lymphomas and leukemias without CNS involvement with a short intensive polychemotherapy: results from the French Pediatric Oncology Society of a randomized trial of 216 children. J Clin Oncol 1991;9:123-132.
9. Sasaki K, Oomochi H, Kawai S et al. National survey of 568 cases of malignant childhood lymphoma in Japan. J Jpn Pediatr Soc 1987;91:690-700 (in Japanese).
10. Patte C, Leverger G, Perel Y et al. Updated results of the LMB86 protocol of the French Pediatric Oncology Society (SFOP) for B-cell non-Hodgkin's lymphoma (B-NHL) with CNS involvement (CNS+) and B-ALL. Med Pediatr Oncol 1990;18:(abstract 397).
11. Bowman WP, Shuster JJ, Cook B et al. Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small non-cleaved-cell lymphoma: a Pediatric Oncology Group Study. J Clin Oncol 1996;14:1252-1261.
12. Reiter A, Schrappe M, Parwaresch R et al. Non-Hodgkin's lymphomas of childhood and adolescence: results of a treatment stratified for biologic subtypes and stage - a report of the Berlin-Frankfurt-Munster Group. J Clin Oncol 1995;13:359-372.
13. Schwenn MR, Blattner SR, Lynch E, Weinstein HJ. HiC-COM: a 2-month intensive chemotherapy regimen for children with stage III and IV Burkitt's lymphoma and B-cell acute lymphoblastic leukemia. J Clin Oncol 1991;9:133-138.
14. Link MP, Donaldson SS, Bernard CW, Shuster JJ, Murphy SB. Results of treatment of childhood localized non-Hodgkin's lymphoma with combination chemotherapy with or without radiotherapy. N Engl J Med 1990;322:1169-1174.
15. Meadows AT, Sposto R, Jenkin RDT et al. Similar efficacy of 6 and 18 months of therapy with four drugs (COMP) for localized non-Hodgkin's lymphoma of children: a report from the Childrens Cancer Study Group. J Clin Oncol 1989;7:92-99.
16. Magrath IT, Janus C, Edwards BK et al. An effective therapy for both undifferentiated (including Burkitt's) lymphomas and lymphoblastic lymphomas in children and young adults. Blood 1984;63:1102-1111.
17. 2 therapy for childhood non-Hodgkin's lymphoma: a report of CCG-551 from the Childrens Cancer Group. J Clin Oncol 1993;11:1024-1032.
18. Weinstein HJ, Lack EE, Cassady JR et al. APO therapy for malignant lymphoma of large cell `histiocytic' type of childhood: analysis of treatment results for 29 patients. Blood 1984;64:422.
19. Hutchinson RE, Bernard CW, Shuster JJ et al. B-cell lineage confers a favorable outcome among children and adolescents with large-cell lymphoma: a Pediatric Oncology Group Study. J Clin Oncol 1995;13:2023-2032.